Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine

NCT01943825 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Dengue
Dengue Fever
Dengue Hemorrhagic Fever

Interventions

BIOLOGICAL: CYD Dengue Vaccine
BIOLOGICAL: CYD Dengue Vaccine
BIOLOGICAL: Japanese Encephalitis Vaccine
BIOLOGICAL: Japanese Encephalitis Vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company

Collaborators

[object Object]